{
    "organizations": [],
    "uuid": "afafee44a42127ccfc6d80a3dbc677d974946bb0",
    "author": "",
    "url": "https://www.reuters.com/article/brief-cascadian-therapeutics-receives-pe/brief-cascadian-therapeutics-receives-pediatric-investigation-plan-waiver-from-the-european-medicines-agency-idUSFWN1OX07Z",
    "ord_in_thread": 0,
    "title": "BRIEF-Cascadian Therapeutics Receives Pediatric Investigation Plan Waiver From The European Medicines Agency",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "January 2, 2018 / 1:39 PM / Updated 26 minutes ago BRIEF-Cascadian Therapeutics Receives Pediatric Investigation Plan Waiver From The European Medicines Agency Reuters Staff 1 Min Read \nJan 2 (Reuters) - Cascadian Therapeutics Inc: \n* CASCADIAN THERAPEUTICS RECEIVES PEDIATRIC INVESTIGATION PLAN WAIVER FROM THE EUROPEAN MEDICINES AGENCY Source text for Eikon: Further company coverage: (Bangalore.newsroom@thomsonreuters.com)",
    "published": "2018-01-02T15:37:00.000+02:00",
    "crawled": "2018-01-02T16:12:15.017+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "january",
        "pm",
        "updated",
        "minute",
        "ago",
        "therapeutic",
        "receives",
        "pediatric",
        "investigation",
        "plan",
        "waiver",
        "european",
        "medicine",
        "agency",
        "reuters",
        "staff",
        "min",
        "read",
        "jan",
        "reuters",
        "cascadian",
        "therapeutic",
        "inc",
        "cascadian",
        "therapeutic",
        "receives",
        "pediatric",
        "investigation",
        "plan",
        "waiver",
        "european",
        "medicine",
        "agency",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}